Evidence map›Paper›PMID 34572290›Full record

ArticleBiomedicines2021

Betulinic Acid Decorated with Polar Groups and Blue Emitting BODIPY Dye: Synthesis, Cytotoxicity, Cell-Cycle Analysis and Anti-HIV Profiling.

David Kodr, Jarmila Stanková, Michaela Rumlová, Petr Džubák, Jiří Řehulka, Tomáš Zimmermann, Ivana Křížová, Soňa Gurská, Marián Hajdúch, Pavel B Drašar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Synthesis ofMagnetic resonance in chemistry : MRC · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Cytotoxic and Anti-Inflammatory Triterpenoids in the Vines and Leaves ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

David KodrDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-5948-6426
Jarmila StankováInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, 77900 Olomouc, Czech Republic.
Michaela RumlováDepartment of Biotechnology, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-5645-8227
Petr DžubákInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, 77900 Olomouc, Czech Republic.ORCID 0000-0002-3098-5969
Jiří ŘehulkaInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, 77900 Olomouc, Czech Republic.
Tomáš ZimmermannDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0003-0529-723X
Ivana KřížováDepartment of Biotechnology, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-0497-4924
Soňa GurskáInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, 77900 Olomouc, Czech Republic.
Marián HajdúchInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, 77900 Olomouc, Czech Republic.
Pavel B DrašarDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0003-0093-7007
Michal JurášekDepartment of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-5069-9716
University of Chemistry and Technology, Prague · CZInstitute of Molecular and Translational Medicine · CZ

Funding

Grantová Agentura České Republiky GA20-19906SMinisterstvo Školství, Mládeže a Tělovýchovy LM2018130Ministerstvo Školství, Mládeže a Tělovýchovy LM2018133
6 · The paper itself

Abstract

Betulinic acid (BA) is a potent triterpene, which has shown promising potential in cancer and HIV-1 treatment. Here, we report a synthesis and biological evaluation of 17 new compounds, including BODIPY labelled analogues derived from BA. The analogues terminated by amino moiety showed increased cytotoxicity (e.g., BA had on CCRF-CEM IC

Indexed as

betulinic acidbevirimatBODIPYcancercell-cyclecytotoxicityfluorescent microscopymaturation inhibitor

Identifiers

PMID34572290
PMCPMC8472287
OpenAlexW3196766500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.